Daniel Deanhofer is originally from Newport News, Virginia. He received his Doctor of Pharmacy degree from Virginia Commonwealth University in 2025 and completed his PGY1 Acute Care Pharmacy Residency at Duke University Hospital. His practice interests include hematologic malignancies and cardio-oncology. In addition to his clinical responsibilities, Dr. Deanhofer serves on the Oncology Formulary Evaluation Team. His research will assess the comparison of R-EPOCH dose level adherence and outcomes in diffuse large B-cell lymphoma. Upon completion of PGY2 pharmacy residency, he plans to pursue a specialty board certification and obtain a position at an academic medical center where he can engage in precepting, research, and teaching opportunities. Outside of pharmacy, he enjoys watching and playing sports, listening to music, and collecting sneakers!